New drug to inhibit bone loss called Skelid (SKEL-id, tiludronate)
April 1997
Sanofi is launching a new drug to inhibit bone loss called Skelid (SKEL-id, tiludronate). It...
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote